DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today presented data on its urinary catheter testing at the Medtech Insight conference "Investment In Innovation (In3) Europe: Bridging European and U.S. Medical Device Innovators, Investors and Companies” held in Paris, France.
